Experimental infection and protection against ... - TI Pharma
Experimental infection and protection against ... - TI Pharma Experimental infection and protection against ... - TI Pharma
Chapter 10 Long-term protection against malaria after experimental sporozoite inoculation Meta Roestenberg 1 , Anne C. Teirlinck 1 , Matthew B.B. McCall 1 , Karina Teelen 1 , Krystelle Nganou Makamdop 1 , Jorien Wiersma 1 , Theo Arens 1 , Pieter Beckers 1 , GeertJan van Gemert 1 , Marga van de Vegte-Bolmer 1 , André J.A.M. van der Ven 2 , Adrian J.F. Luty 1 , Cornelus C. Hermsen 1 , Robert W. Sauerwein 1 1 Radboud University Nijmegen Medical Centre, Department of Medical Microbiology, Nijmegen, The Netherlands 2 Radboud University Nijmegen Medical Centre, Department of Internal Medicine, Nijmegen, The Netherlands [A J A M van der Ven) Lancet 2011; 377:1770-1776
194 Chapter 10 Abstract Induction of long-lived immunity to Plasmodium falciparum (Pf) is a major obstacle to malaria vaccine development. Recently we showed that immunity to Pf can be induced experimentally in 10/10 of malaria-naïve volunteers through immunisation by bites of Pf-infected mosquitoes whilst simultaneously preventing disease by chloroquine prophylaxis. This immunity was associated with parasite-specific production of IFNγ and IL-2 by pluripotent effector memory cells in vitro. Here we explore the persistence of protection and immune responses in the same volunteers. In an open-label study conducted 28 months after immunisation, six previously immune volunteers were re-challenged by the bites of five Pf-infected mosquitoes. Five naive volunteers served as infection controls. The primary outcome was detection of blood-stage parasitemia by microscopy. The kinetics of parasitemia were assessed by real-time quantitative PCR (Q-PCR) and clinical signs and symptoms were recorded. In vitro production of IFNγ and IL-2 by effector memory T cells was studied following stimulation with sporozoites and Pf-infected red blood cells. This study is registered with clinicaltrials.gov, number NCT00757887. Four of six immune volunteers were fully protected against re-challenge. Q-PCRbased detection of blood-stage parasites in these individuals was negative throughout follow-up. Patency in the remaining two immunised volunteers was markedly delayed. In vitro assays revealed the long-term persistence of parasitespecific pluripotent effector memory T cell responses in protected volunteers. We demonstrate that immunity to Pf in human volunteers can persist for more than two years using an experimental immunisation protocol. Immunity was paralleled by maintenance of Pf-specific pluripotent effector memory T cells. These findings are unprecedented and demonstrate that artificially induced immunity may be longer-lasting than generally observed after natural exposure. These results open a novel avenue for research into mechanisms of malaria immunity.
- Page 144 and 145: NF135.C10: a new Plasmodium falcipa
- Page 146 and 147: NF135.C10: a new Plasmodium falcipa
- Page 148 and 149: NF135.C10: a new Plasmodium falcipa
- Page 150 and 151: NF135.C10: a new Plasmodium falcipa
- Page 152 and 153: Chapter 8 Induction of malaria in v
- Page 154 and 155: Induction of malaria in volunteers
- Page 156 and 157: Induction of malaria in volunteers
- Page 158 and 159: Induction of malaria in volunteers
- Page 160 and 161: Induction of malaria in volunteers
- Page 162 and 163: Induction of malaria in volunteers
- Page 164 and 165: Induction of malaria in volunteers
- Page 166 and 167: Induction of malaria in volunteers
- Page 168 and 169: Induction of malaria in volunteers
- Page 170 and 171: Induction of malaria in volunteers
- Page 172: Section 3 Whole parasite inoculatio
- Page 175 and 176: 174 Chapter 9 Abstract An effective
- Page 177 and 178: 176 Chapter 9 Figure 1. Study desig
- Page 179 and 180: 178 Chapter 9 followed by five iden
- Page 181 and 182: 180 Chapter 9 Figure 2. Parasitemia
- Page 183 and 184: 182 Chapter 9 Test Day I-1 Day C-1
- Page 185 and 186: 184 Chapter 9 strain P. falciparum-
- Page 187 and 188: 186 Chapter 9 protective role in ot
- Page 189 and 190: 188 Chapter 9 References 1. Greenwo
- Page 191 and 192: 190 Chapter 9 27. Orjih AU. Acute m
- Page 193: 192 Chapter 9 medium A (Caltag Labo
- Page 197 and 198: 196 Chapter 10 Pre-erythrocytic sta
- Page 199 and 200: 198 Chapter 10 procedures described
- Page 201 and 202: 200 Chapter 10 by hand-dissection.
- Page 203 and 204: 202 Chapter 10 Figure 3. Mean numbe
- Page 205 and 206: 204 Chapter 10 Figure 4. Number of
- Page 207 and 208: 206 Chapter 10 temperature (Pearson
- Page 209 and 210: 208 Chapter 10 immune modulating ef
- Page 211 and 212: 210 Chapter 10 cytokine measurement
- Page 213 and 214: 212 Chapter 10 14. Hermsen CC, Telg
- Page 216 and 217: Chapter 11 General Discussion
- Page 218 and 219: General Discussion 217 occurrence o
- Page 220 and 221: General Discussion 219 mediating th
- Page 222 and 223: General Discussion 221 AMA1 express
- Page 224 and 225: General Discussion 223 troponins ca
- Page 226 and 227: General Discussion 225 and between
- Page 228 and 229: General Discussion 227 immunologica
- Page 230 and 231: General Discussion 229 to induce pr
- Page 232 and 233: General Discussion 231 Conclusions
- Page 234 and 235: General Discussion 233 References 1
- Page 236 and 237: General Discussion 235 polymorphonu
- Page 238 and 239: General Discussion 237 57. Church L
- Page 240 and 241: General Discussion 239 85. Beier JC
- Page 242 and 243: General Discussion 241 118. Mueller
194 Chapter 10<br />
Abstract<br />
Induction of long-lived immunity to Plasmodium falciparum (Pf) is a major<br />
obstacle to malaria vaccine development. Recently we showed that immunity to<br />
Pf can be induced experimentally in 10/10 of malaria-naïve volunteers through<br />
immunisation by bites of Pf-infected mosquitoes whilst simultaneously<br />
preventing disease by chloroquine prophylaxis. This immunity was associated<br />
with parasite-specific production of IFNγ <strong>and</strong> IL-2 by pluripotent effector<br />
memory cells in vitro. Here we explore the persistence of <strong>protection</strong> <strong>and</strong><br />
immune responses in the same volunteers.<br />
In an open-label study conducted 28 months after immunisation, six previously<br />
immune volunteers were re-challenged by the bites of five Pf-infected<br />
mosquitoes. Five naive volunteers served as <strong>infection</strong> controls. The primary<br />
outcome was detection of blood-stage parasitemia by microscopy. The kinetics<br />
of parasitemia were assessed by real-time quantitative PCR (Q-PCR) <strong>and</strong> clinical<br />
signs <strong>and</strong> symptoms were recorded. In vitro production of IFNγ <strong>and</strong> IL-2 by<br />
effector memory T cells was studied following stimulation with sporozoites <strong>and</strong><br />
Pf-infected red blood cells. This study is registered with clinicaltrials.gov, number<br />
NCT00757887.<br />
Four of six immune volunteers were fully protected <strong>against</strong> re-challenge. Q-PCRbased<br />
detection of blood-stage parasites in these individuals was negative<br />
throughout follow-up. Patency in the remaining two immunised volunteers was<br />
markedly delayed. In vitro assays revealed the long-term persistence of parasitespecific<br />
pluripotent effector memory T cell responses in protected volunteers.<br />
We demonstrate that immunity to Pf in human volunteers can persist for more<br />
than two years using an experimental immunisation protocol. Immunity was<br />
paralleled by maintenance of Pf-specific pluripotent effector memory T cells.<br />
These findings are unprecedented <strong>and</strong> demonstrate that artificially induced<br />
immunity may be longer-lasting than generally observed after natural exposure.<br />
These results open a novel avenue for research into mechanisms of malaria<br />
immunity.